Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-09-01

Clinical Trial Update: Age Gene/Environment Susceptibility Reykjavik Study

View source ↗

Summary

The Icelandic Heart Association reports the completed status of the Age Gene/Environment Susceptibility Reykjavik Study assessing risks related to neoplasms.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Icelandic Heart Association | Conditions: Neoplasms | Status: COMPLETED